💰 Cost in India
Full RIF investigation: ₹60,000–₹1,50,000 (ERA + hysteroscopy + PGT-A + endometritis + immunology panel)
📊 Success Rate
After targeted intervention: implantation rate per euploid embryo transfer: 60–70%; chronic endometritis treatment restores receptivity in 70–80% of cases
⏱️ Duration
Full workup: 2–3 months; PGT-A cycle adds 1 additional month for biopsy results
📂 Category
❤️‍🩹 Conditions

What is Recurrent Implantation Failure?

💡 Recurrent implantation failure (RIF) is defined as failure of ≥3 good-quality embryo transfers or ≥2 blastocyst transfers. Causes: embryo aneuploidy (50–60%), displaced window of implantation (20–25%), chronic endometritis (30–60%), uterine anomalies, and immunological factors. Systematic workup significantly improves outcomes.

Recurrent implantation failure (RIF) is the clinical condition in which embryo transfer repeatedly fails to result in implantation or ongoing pregnancy across multiple IVF cycles, despite the transfer of morphologically good-quality embryos. It requires systematic investigation before further treatment.

🇮🇳 India Context: Recurrent Implantation Failure is widely assessed and treated across major Indian fertility centres including Chennai, Mumbai, Bangalore, Delhi, and Hyderabad.

What are the key characteristics of Recurrent Implantation Failure?

  • European consensus definition: failure of ≥3 good-quality embryo transfers OR ≥2 blastocyst transfers
  • Embryo aneuploidy: responsible for 50–60% of RIF cases — addressed by PGT-A genetic testing of blastocysts
  • Displaced window of implantation: 20–25% of RIF cases — identified by ERA (endometrial receptivity array) biopsy
  • Chronic endometritis: 30–60% of RIF patients — diagnosed by CD138 immunostaining of endometrial biopsy
  • Uterine abnormalities: submucosal fibroids, polyps, adhesions (Asherman's), uterine septum — diagnosed by hysteroscopy
  • Immunological factors: elevated uterine NK cells, antiphospholipid syndrome, inherited thrombophilia
  • Elevated sperm DNA fragmentation in male partner: testicular sperm for ICSI may improve outcomes in RIF
  • RIF workup protocol: ERA + hysteroscopy + endometritis biopsy + PGT-A + thrombophilia + NK cell testing

How does Recurrent Implantation Failure work?

1
After each failed transfer, investigation escalates systematically: cavity assessment → receptivity → endometritis → immunology
2
ERA test: endometrial biopsy at expected window of implantation — RNA sequencing classifies receptivity status
3
Chronic endometritis treated with doxycycline or ciprofloxacin (14-day course) — repeat biopsy confirms clearance
4
PGT-A: trophectoderm biopsy from blastocysts; only euploid (chromosomally normal) embryos selected for transfer
5
Immunological investigation: peripheral blood NK cell testing, antiphospholipid antibody screen, thrombophilia panel
6
Intralipid infusion or low-dose prednisolone used empirically in suspected NK cell hyperactivity — evidence still emerging

Why does Recurrent Implantation Failure matter in fertility?

RIF is one of the most clinically and emotionally challenging IVF outcomes. Systematic investigation and targeted intervention significantly improves subsequent outcomes: PGT-A raises implantation rate per transfer to 60–70% in euploid cycles; ERA-guided personalised embryo transfer (pET) eliminates displaced WOI as a cause; chronic endometritis treatment restores receptivity in 70–80% of cases within one menstrual cycle. RIF patients should be managed in specialist reproductive medicine clinics with access to comprehensive investigation panels. In India, ERA and endometritis diagnosis are available at specialist centres in Delhi, Mumbai, Bangalore, and Hyderabad.

FAQs about Recurrent Implantation Failure

What are the causes of recurrent implantation failure?

Causes: embryo aneuploidy (50–60% of cases), displaced window of implantation (20–25%), chronic endometritis (30–60%), uterine abnormalities (polyps, fibroids, adhesions, septum), immunological factors (NK cells, antiphospholipid syndrome, thrombophilia), and elevated sperm DNA fragmentation in the male partner.

How is recurrent implantation failure investigated?

RIF workup: ERA test (displaced window of implantation), hysteroscopy (uterine cavity), endometrial biopsy with CD138 staining (chronic endometritis), PGT-A of blastocysts (embryo aneuploidy), thrombophilia screen, peripheral NK cell testing, and male partner sperm DNA fragmentation. Investigation takes 2–3 months.

What is the treatment for recurrent implantation failure?

Treatment is targeted to the cause found on investigation. PGT-A for embryo aneuploidy; personalised embryo transfer (pET) guided by ERA for displaced WOI; antibiotics (doxycycline 14 days) for chronic endometritis; hysteroscopic surgery for uterine abnormalities; anticoagulation for thrombophilia.

Can you get pregnant with recurrent implantation failure?

Yes. After systematic investigation and targeted treatment, the majority of RIF patients achieve pregnancy. PGT-A increases implantation rate to 60–70% per euploid transfer. ERA-guided pET eliminates displaced WOI as a cause. Chronic endometritis treatment restores receptivity in 70–80% within one cycle.

How many failed IVF cycles is considered recurrent implantation failure?

The European ESHRE consensus defines RIF as failure of ≥3 transfers of morphologically good-quality embryos, or ≥2 blastocyst transfers. Some clinics begin investigation after 2 failed blastocyst transfers in women over 37 — given the time cost of additional cycles and the high yield of investigation.

🏥 Find Specialists for Recurrent Implantation Failure in India

Connect with verified fertility specialists who can guide you through recurrent implantation failure.

Medical Disclaimer: This page is for educational purposes only and does not constitute medical advice. Reviewed by Dr. Priya Sharma (MBBS, MD OB-GYN). Success rates and costs are approximate and vary by clinic and individual case. Always consult a qualified fertility specialist. Last updated: April 2026.